1Asperen JV, Rijcken WRP, Lammers JHCM. Application of physiologically based toxicokinetic modeling to study the impact of the exosure scenario on the toxicokinetics and the behavioural effects of toluene in rats. Toxicol Lett,2003,138:51-62.
2Collins AS, Sumner SC J, Borghoff SJ, et al. A physiological model for tert-amyl methyl ether and tert-amyl alcohol:hypothesis testing of model structures. Toxicol Sci, 1999,49:15-28.
3Fennell TR. Brown CDA physiologically based pharnacokinetic model for ethylene oxide in mouse rat and human. Toxicol Appl Phaarmacol, 2001,173:161-175.
4Simmons JE , Boyes WK, Bushnell PJ, et al. A physiologically pharmacokinetic model for trichloroethylene in the male LongEvans rat. Toxicol Sci, 2002,69: 3-15.
5Gargas ML,Tyler TR, Sweeney LM, et al. A toxicolinetic study of inhalaed ethylene glycol monomethyl ether (2-ME) and validation of a physiologically based pharmacokinetic model for the pregnant rat and human. Toxicol Appl Pharmacol, 2000,165:53-62.
6Lee KM, Dill JA, Chou BJ, et al. Physiologically based pharmacokinetic model for chronic inhalation of 2-butoxyethanolanol. Toxicol Appl Pharmacol, 1998, 153: 211-226.
7Filser JG, Schmidbauer R, Rampf F, et al. Toxicokinetics of inhaled propylene in mouse, rat, and human. Toxicol Appl Pharmacol, 2000,169:40-51.
8Sweeney LM, Gargas ML, Strother DE, et al. Physiologically based pharmacokinetic model parameter estimation and sensitivity and variability analyses for acrylonitrile disposition in humans. Toxicol Sci, 2003,71: 27-40.
9Nestorov I. Whole body pharmacokinetic models. Clin Pharmacokinet, 2003,42: 883 -908.
10Adersen ME. Toxicokinetic modeling and its applications in chemical risk assessment,Toxicol Lett,2003,138:9-27.
7Kawai R.Physiologically based pharmcokinetics modeling for the cyclosporin derivatives IV[J].Yukubustu Dotai,1994,9(suppl):s66-s69.
8Timchalk C,Nolan R J,Mendrala A L,et al.A physiologically Based Pharmacokinetic and phannacodynamic(PBPK/PD)model for the organophosphate insecticide chlorpyrifos in rata and humans[J].Toxicol Sci.2002,66:34-53.
9Corley R A,Gies R A,Wu H,et al.Development of a physiologically based pharmacokinetic model for propylene glycol monomethyl ether and its acetate in rats and humans[J].Toxicology Letters,2005,156:193-213.
10Liu L c,Pang K S.An integrated approach to model hepatic drug clearance[J].European Journal of pharmaceutical sciences,2006,29:215-230.
